# ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

> **NCT06676280** · PHASE4 · RECRUITING · sponsor: **Jung-min Ahn** · enrollment: 5000 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Aspirin
- **DRUG:** High-intensity statin
- **DRUG:** Guideline-directed statin therapy

## Key facts

- **NCT ID:** NCT06676280
- **Lead sponsor:** Jung-min Ahn
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-24
- **Primary completion:** 2035-03-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06676280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06676280, "ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06676280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*